Demand for implantable drug eluting devices will increase through 2036, with contraceptive drug eluting devices at a 39.4% share in 2026 as the leading product segment. The market was valued at USD 15.20 billion in 2025 and is expected to reach USD 28.85 billion by 2036, creating an incremental opportunity of USD 12.74 billion.